Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast.

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ ... as a frequently ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

We have two types of hair, says dermatologist Elizabeth Houshmand. Vellus hairs, or “peach fuzz,” cover virtually our entire ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) ...

Dipendra Malhotra, former head of analytics, AI and data at Morgan Stanley's wealth unit, will help drive technology ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Aashima Gupta leads health tech projects for the massive cloud computing company. Here, she shares why she’s excited about ...